Skip to content
healthcare.dev

Abacavir and Lamivudine

NDC 65862-335, Abacavir and Lamivudine, tablet, film coated, from Aurobindo Pharma Limited.

Product NDC
65862-335
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090159
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-335 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABACAVIR SULFATE600 mg/1
  • LAMIVUDINE300 mg/1

Pharmacologic classes

Cytochrome P450 1A1 Inhibitors [MoA]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
65862-335-106586203351010 BLISTER PACK in 1 CARTON (65862-335-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK
65862-335-30658620335301 BOTTLE in 1 CARTON (65862-335-30) / 30 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/deda1a24-2f51-4601-9881-347f47270940
  • NADAC price for package 65862033530

    GET /v1/drugs/nadac/65862033530

Use it

Look up 65862-335 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-335 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-335. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.